Mankind Pharma
MANKIND · Pharma > Pharmaceuticals & Drugs Listing date: May 9, 2023

Stock Price vs Company Growth
1d
2.6%
1w
1.6%
1m
6.4%
3m
16.1%
6m
25.0%
1y
3.1%
all
20.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 2,618 2.6%
2,222
2,640
Company Overview

Sales
14,278 Cr
Growth: 16.4%
Profit after Tax
1,913 Cr
Growth: 7.5%
Large Cap
1,08,129 Cr
P/E: 56.6x
Industry P/E: 32.3x
Fundamentals

Sales (Cr) ₹ 14,278
Growth 16.4%
EBITDA 25.3%
P/S 7.6x
Dividend 0.0%
P/E 56.6x
Book Value ₹ 395
PEG Ratio 3.4x
ROE 12.3%
P/B 6.5x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is India’s one of the leading pharmaceutical company with a diversified portfolio - from pharma and super specialty to consumer healthcare backed by strong in-house R&D capabilities with an established and deeply penetrated presence across India. The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Investors (1)
Followers (2)